CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Income Statement [Abstract]
Net sales	$ 479.6	$ 484.8
Cost of products sold	394.7	412.2
Gross profit	84.9	72.6
Selling and general expense	54.8	63.3
Research and development expense	5.5	6.3
Intangible asset amortization expense	16.0	15.4
Total nonmanufacturing expenses	76.3	85.0
Goodwill impairment expense	0.0	411.9
Restructuring and other impairment expense	1.3	6.3
Operating profit (loss)	7.3	(430.6)
Interest expense	17.5	17.8
Other income (expense), net	1.5	(1.8)
Loss before income taxes	(8.7)	(450.2)
Income tax expense (benefit), net	3.0	(24.7)
Net loss	$ (11.7)	$ (425.5)
Net loss per share:
Basic (in dollars per share)	$ (0.22)	$ (7.82)
Diluted (in dollars per share)	$ (0.22)	$ (7.82)
Weighted average shares outstanding:
Basic (in shares)	54,828,500	54,447,200
Diluted (in shares)	54,828,500	54,447,200